Abstract:Copyright: © 2013 Qiu L. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited In the latest several decades, we have witnessed the striking development of synthetic polymers as drug carriers from the early issue as implant agents to update various nano-scaled drug delivery systems via transmucosal, oral or intravenous administration. Of these, polymeric nanoparticles delivering anti-cancer drugs, biomacromolecular antibody or genetic substance such as DNA or siRNA to tumor have received predominant attention. In these delivery systems, the polymers play important roles to improve the solubility, regulate the biodistribution, prolong the half-life and control the release of drug, consequently enhanced therapy efficacy and minimized side effect has been expected. By now, quite many polymers have been explored and it has been found that different pharmaceutical formulations would lead to different results. Therefore, the rational design of polymer and formulation, and then the proper combination of both of them is the prerequisite to fabricate a successful drug delivery system. The major method to design optimal polymer can be classified to top-down and bottom-up methods [1]. Bottomup design methods prepare the polymer derivations on the basis of chemical properties of polymers, while top-down design method is adopted to modify the polymer considering the requirement of cancer therapy. Using bottom-up method, it is easier for chemists to acquire a large quantity of novel polymers, but most of them finally fail to meet the demand of clinical application. On the contrary, top-down method directly aims to clinical application of polymers and the corresponding formulation. With this idea, how to synthesize objective polymer is always the difficulty for those researches working in clinic. Obviously, merging these two methods together is an ideal method to facilitate the development of functional polymers and their transfer from the lab to practical application. Herein, I focus on amphiphilic polymer design for cancer therapy.

Biopolymeric Prodrug Systems as Potential Antineoplastic Therapy

Polymeric Prodrug by Supramolecular Polymerization

Polymer-Based Prodrugs: Improving Tumor Targeting and the Solubility of Small Molecule Drugs in Cancer Therapy

Polymer-Based Drug Delivery Systems for Cancer Therapeutics

Supramolecular polymeric prodrug micelles for efficient anticancer drug delivery

Natural Polymeric Nanobiocomposites for Anti-Cancer Drug Delivery Therapeutics: A Recent Update

Alleviation of Tumor Invasion by the Development of Natural Polymerbased Low-risk Chemotherapeutic Systems - review on the Malignant Carcinoma Treatments

Emerging natural polymer-based architectured nanotherapeutics for the treatment of cancer

Tumor Stimulus-Responsive Biodegradable Diblock Copolymer Conjugates as Efficient Anti-Cancer Nanomedicines

Polymers with Distinctive Anticancer Mechanism That Kills MDR Cancer Cells and Inhibits Tumor Metastasis.

Polyprodrug Nanomedicines: an Emerging Paradigm for Cancer Therapy

Targeting Cancer using Polymeric Nanoparticle mediated Combination Chemotherapy

Thermosensitive polymer prodrug nanoparticles prepared by an all-aqueous nanoprecipitation process and application to combination therapy

Biopolymer-Based Nanomedicine for Cancer Therapy: Opportunities and Challenges

How Are Natural-Based Polymers Shaping the Future of Cancer Immunotherapy—A Review

Synergistic Therapy of a Naturally Inspired Glycopolymer‐Based Biomimetic Nanomedicine Harnessing Tumor Genomic Instability

Biopolymeric nanocarriers in cancer therapy: unleashing the potency of bioactive anticancer compounds for enhancing drug delivery

Advancements in Cancer Therapeutics: Current Paradigms in Applying Biodegradable Polymer Nanoparticles for Enhanced Management

Chemically Modified Natural Polymer-Based Theranostic Nanomedicines: Are They the Golden Gate toward a de Novo Clinical Approach against Cancer?

Rational Design of Synthetic Polymers As Drug Carriers for Cancer Therapy

Polymer-Based Prodrugs For Cancer Chemotherapy